nodes	percent_of_prediction	percent_of_DWPC	metapath
Cefpodoxime—Vomiting—Irinotecan—breast cancer	0.00022	0.00022	CcSEcCtD
Cefpodoxime—Sinusitis—Doxorubicin—breast cancer	0.00022	0.00022	CcSEcCtD
Cefpodoxime—Dizziness—Fluorouracil—breast cancer	0.000219	0.000219	CcSEcCtD
Cefpodoxime—Agranulocytosis—Doxorubicin—breast cancer	0.000219	0.000219	CcSEcCtD
Cefpodoxime—Rash—Irinotecan—breast cancer	0.000218	0.000218	CcSEcCtD
Cefpodoxime—Rash—Mitoxantrone—breast cancer	0.000218	0.000218	CcSEcCtD
Cefpodoxime—Dermatitis—Mitoxantrone—breast cancer	0.000218	0.000218	CcSEcCtD
Cefpodoxime—Dermatitis—Irinotecan—breast cancer	0.000218	0.000218	CcSEcCtD
Cefpodoxime—Musculoskeletal discomfort—Docetaxel—breast cancer	0.000218	0.000218	CcSEcCtD
Cefpodoxime—Chills—Methotrexate—breast cancer	0.000218	0.000218	CcSEcCtD
Cefpodoxime—Headache—Irinotecan—breast cancer	0.000217	0.000217	CcSEcCtD
Cefpodoxime—Headache—Mitoxantrone—breast cancer	0.000217	0.000217	CcSEcCtD
Cefpodoxime—Hypotension—Capecitabine—breast cancer	0.000217	0.000217	CcSEcCtD
Cefpodoxime—Insomnia—Docetaxel—breast cancer	0.000217	0.000217	CcSEcCtD
Cefpodoxime—Paraesthesia—Docetaxel—breast cancer	0.000215	0.000215	CcSEcCtD
Cefpodoxime—Erythema multiforme—Epirubicin—breast cancer	0.000215	0.000215	CcSEcCtD
Cefpodoxime—Alopecia—Methotrexate—breast cancer	0.000215	0.000215	CcSEcCtD
Cefpodoxime—Vomiting—Gemcitabine—breast cancer	0.000215	0.000215	CcSEcCtD
Cefpodoxime—Dyspnoea—Docetaxel—breast cancer	0.000213	0.000213	CcSEcCtD
Cefpodoxime—Somnolence—Docetaxel—breast cancer	0.000213	0.000213	CcSEcCtD
Cefpodoxime—Rash—Gemcitabine—breast cancer	0.000213	0.000213	CcSEcCtD
Cefpodoxime—Dermatitis—Gemcitabine—breast cancer	0.000213	0.000213	CcSEcCtD
Cefpodoxime—Tinnitus—Epirubicin—breast cancer	0.000212	0.000212	CcSEcCtD
Cefpodoxime—Haemoglobin—Doxorubicin—breast cancer	0.000211	0.000211	CcSEcCtD
Cefpodoxime—Headache—Gemcitabine—breast cancer	0.000211	0.000211	CcSEcCtD
Cefpodoxime—Musculoskeletal discomfort—Capecitabine—breast cancer	0.000211	0.000211	CcSEcCtD
Cefpodoxime—Vomiting—Fluorouracil—breast cancer	0.000211	0.000211	CcSEcCtD
Cefpodoxime—Rhinitis—Doxorubicin—breast cancer	0.000211	0.000211	CcSEcCtD
Cefpodoxime—Dyspepsia—Docetaxel—breast cancer	0.000211	0.000211	CcSEcCtD
Cefpodoxime—Haemorrhage—Doxorubicin—breast cancer	0.00021	0.00021	CcSEcCtD
Cefpodoxime—Insomnia—Capecitabine—breast cancer	0.00021	0.00021	CcSEcCtD
Cefpodoxime—Rash—Fluorouracil—breast cancer	0.000209	0.000209	CcSEcCtD
Cefpodoxime—Dermatitis—Fluorouracil—breast cancer	0.000209	0.000209	CcSEcCtD
Cefpodoxime—Paraesthesia—Capecitabine—breast cancer	0.000208	0.000208	CcSEcCtD
Cefpodoxime—Decreased appetite—Docetaxel—breast cancer	0.000208	0.000208	CcSEcCtD
Cefpodoxime—Hypersensitivity—Paclitaxel—breast cancer	0.000208	0.000208	CcSEcCtD
Cefpodoxime—Headache—Fluorouracil—breast cancer	0.000208	0.000208	CcSEcCtD
Cefpodoxime—Oedema peripheral—Doxorubicin—breast cancer	0.000207	0.000207	CcSEcCtD
Cefpodoxime—Dysgeusia—Methotrexate—breast cancer	0.000207	0.000207	CcSEcCtD
Cefpodoxime—Gastrointestinal disorder—Docetaxel—breast cancer	0.000207	0.000207	CcSEcCtD
Cefpodoxime—Dyspnoea—Capecitabine—breast cancer	0.000207	0.000207	CcSEcCtD
Cefpodoxime—Fatigue—Docetaxel—breast cancer	0.000206	0.000206	CcSEcCtD
Cefpodoxime—Nausea—Mitoxantrone—breast cancer	0.000206	0.000206	CcSEcCtD
Cefpodoxime—Nausea—Irinotecan—breast cancer	0.000206	0.000206	CcSEcCtD
Cefpodoxime—Constipation—Docetaxel—breast cancer	0.000205	0.000205	CcSEcCtD
Cefpodoxime—Pain—Docetaxel—breast cancer	0.000205	0.000205	CcSEcCtD
Cefpodoxime—Back pain—Methotrexate—breast cancer	0.000205	0.000205	CcSEcCtD
Cefpodoxime—Dyspepsia—Capecitabine—breast cancer	0.000204	0.000204	CcSEcCtD
Cefpodoxime—Chills—Epirubicin—breast cancer	0.000204	0.000204	CcSEcCtD
Cefpodoxime—Asthenia—Paclitaxel—breast cancer	0.000203	0.000203	CcSEcCtD
Cefpodoxime—Decreased appetite—Capecitabine—breast cancer	0.000202	0.000202	CcSEcCtD
Cefpodoxime—Alopecia—Epirubicin—breast cancer	0.000201	0.000201	CcSEcCtD
Cefpodoxime—Nausea—Gemcitabine—breast cancer	0.0002	0.0002	CcSEcCtD
Cefpodoxime—Gastrointestinal disorder—Capecitabine—breast cancer	0.0002	0.0002	CcSEcCtD
Cefpodoxime—Fatigue—Capecitabine—breast cancer	0.0002	0.0002	CcSEcCtD
Cefpodoxime—Pruritus—Paclitaxel—breast cancer	0.0002	0.0002	CcSEcCtD
Cefpodoxime—Erythema multiforme—Doxorubicin—breast cancer	0.000199	0.000199	CcSEcCtD
Cefpodoxime—Constipation—Capecitabine—breast cancer	0.000198	0.000198	CcSEcCtD
Cefpodoxime—Pain—Capecitabine—breast cancer	0.000198	0.000198	CcSEcCtD
Cefpodoxime—Feeling abnormal—Docetaxel—breast cancer	0.000197	0.000197	CcSEcCtD
Cefpodoxime—Nausea—Fluorouracil—breast cancer	0.000197	0.000197	CcSEcCtD
Cefpodoxime—Ill-defined disorder—Methotrexate—breast cancer	0.000196	0.000196	CcSEcCtD
Cefpodoxime—Tinnitus—Doxorubicin—breast cancer	0.000196	0.000196	CcSEcCtD
Cefpodoxime—Gastrointestinal pain—Docetaxel—breast cancer	0.000196	0.000196	CcSEcCtD
Cefpodoxime—Anaemia—Methotrexate—breast cancer	0.000195	0.000195	CcSEcCtD
Cefpodoxime—Flatulence—Epirubicin—breast cancer	0.000195	0.000195	CcSEcCtD
Cefpodoxime—Tension—Epirubicin—breast cancer	0.000194	0.000194	CcSEcCtD
Cefpodoxime—Dysgeusia—Epirubicin—breast cancer	0.000194	0.000194	CcSEcCtD
Cefpodoxime—Diarrhoea—Paclitaxel—breast cancer	0.000193	0.000193	CcSEcCtD
Cefpodoxime—Nervousness—Epirubicin—breast cancer	0.000192	0.000192	CcSEcCtD
Cefpodoxime—Back pain—Epirubicin—breast cancer	0.000191	0.000191	CcSEcCtD
Cefpodoxime—Feeling abnormal—Capecitabine—breast cancer	0.000191	0.000191	CcSEcCtD
Cefpodoxime—Malaise—Methotrexate—breast cancer	0.000191	0.000191	CcSEcCtD
Cefpodoxime—Vertigo—Methotrexate—breast cancer	0.00019	0.00019	CcSEcCtD
Cefpodoxime—Gastrointestinal pain—Capecitabine—breast cancer	0.00019	0.00019	CcSEcCtD
Cefpodoxime—Body temperature increased—Docetaxel—breast cancer	0.000189	0.000189	CcSEcCtD
Cefpodoxime—Abdominal pain—Docetaxel—breast cancer	0.000189	0.000189	CcSEcCtD
Cefpodoxime—Leukopenia—Methotrexate—breast cancer	0.000189	0.000189	CcSEcCtD
Cefpodoxime—Chills—Doxorubicin—breast cancer	0.000189	0.000189	CcSEcCtD
Cefpodoxime—Dizziness—Paclitaxel—breast cancer	0.000187	0.000187	CcSEcCtD
Cefpodoxime—Alopecia—Doxorubicin—breast cancer	0.000186	0.000186	CcSEcCtD
Cefpodoxime—Cough—Methotrexate—breast cancer	0.000185	0.000185	CcSEcCtD
Cefpodoxime—Urticaria—Capecitabine—breast cancer	0.000184	0.000184	CcSEcCtD
Cefpodoxime—Ill-defined disorder—Epirubicin—breast cancer	0.000184	0.000184	CcSEcCtD
Cefpodoxime—Body temperature increased—Capecitabine—breast cancer	0.000183	0.000183	CcSEcCtD
Cefpodoxime—Abdominal pain—Capecitabine—breast cancer	0.000183	0.000183	CcSEcCtD
Cefpodoxime—Convulsion—Methotrexate—breast cancer	0.000183	0.000183	CcSEcCtD
Cefpodoxime—Anaemia—Epirubicin—breast cancer	0.000183	0.000183	CcSEcCtD
Cefpodoxime—Agitation—Epirubicin—breast cancer	0.000182	0.000182	CcSEcCtD
Cefpodoxime—Flatulence—Doxorubicin—breast cancer	0.00018	0.00018	CcSEcCtD
Cefpodoxime—Myalgia—Methotrexate—breast cancer	0.00018	0.00018	CcSEcCtD
Cefpodoxime—Chest pain—Methotrexate—breast cancer	0.00018	0.00018	CcSEcCtD
Cefpodoxime—Tension—Doxorubicin—breast cancer	0.00018	0.00018	CcSEcCtD
Cefpodoxime—Vomiting—Paclitaxel—breast cancer	0.00018	0.00018	CcSEcCtD
Cefpodoxime—Dysgeusia—Doxorubicin—breast cancer	0.000179	0.000179	CcSEcCtD
Cefpodoxime—Malaise—Epirubicin—breast cancer	0.000178	0.000178	CcSEcCtD
Cefpodoxime—Rash—Paclitaxel—breast cancer	0.000178	0.000178	CcSEcCtD
Cefpodoxime—Dermatitis—Paclitaxel—breast cancer	0.000178	0.000178	CcSEcCtD
Cefpodoxime—Discomfort—Methotrexate—breast cancer	0.000178	0.000178	CcSEcCtD
Cefpodoxime—Nervousness—Doxorubicin—breast cancer	0.000178	0.000178	CcSEcCtD
Cefpodoxime—Vertigo—Epirubicin—breast cancer	0.000178	0.000178	CcSEcCtD
Cefpodoxime—Syncope—Epirubicin—breast cancer	0.000177	0.000177	CcSEcCtD
Cefpodoxime—Leukopenia—Epirubicin—breast cancer	0.000177	0.000177	CcSEcCtD
Cefpodoxime—Back pain—Doxorubicin—breast cancer	0.000177	0.000177	CcSEcCtD
Cefpodoxime—Headache—Paclitaxel—breast cancer	0.000177	0.000177	CcSEcCtD
Cefpodoxime—Hypersensitivity—Docetaxel—breast cancer	0.000176	0.000176	CcSEcCtD
Cefpodoxime—Palpitations—Epirubicin—breast cancer	0.000175	0.000175	CcSEcCtD
Cefpodoxime—Confusional state—Methotrexate—breast cancer	0.000174	0.000174	CcSEcCtD
Cefpodoxime—Loss of consciousness—Epirubicin—breast cancer	0.000174	0.000174	CcSEcCtD
Cefpodoxime—Cough—Epirubicin—breast cancer	0.000173	0.000173	CcSEcCtD
Cefpodoxime—Anaphylactic shock—Methotrexate—breast cancer	0.000173	0.000173	CcSEcCtD
Cefpodoxime—Asthenia—Docetaxel—breast cancer	0.000172	0.000172	CcSEcCtD
Cefpodoxime—Convulsion—Epirubicin—breast cancer	0.000171	0.000171	CcSEcCtD
Cefpodoxime—Hypertension—Epirubicin—breast cancer	0.000171	0.000171	CcSEcCtD
Cefpodoxime—Hypersensitivity—Capecitabine—breast cancer	0.000171	0.000171	CcSEcCtD
Cefpodoxime—Ill-defined disorder—Doxorubicin—breast cancer	0.00017	0.00017	CcSEcCtD
Cefpodoxime—Pruritus—Docetaxel—breast cancer	0.000169	0.000169	CcSEcCtD
Cefpodoxime—Anaemia—Doxorubicin—breast cancer	0.000169	0.000169	CcSEcCtD
Cefpodoxime—Thrombocytopenia—Methotrexate—breast cancer	0.000169	0.000169	CcSEcCtD
Cefpodoxime—Chest pain—Epirubicin—breast cancer	0.000168	0.000168	CcSEcCtD
Cefpodoxime—Myalgia—Epirubicin—breast cancer	0.000168	0.000168	CcSEcCtD
Cefpodoxime—Agitation—Doxorubicin—breast cancer	0.000168	0.000168	CcSEcCtD
Cefpodoxime—Anxiety—Epirubicin—breast cancer	0.000168	0.000168	CcSEcCtD
Cefpodoxime—Nausea—Paclitaxel—breast cancer	0.000168	0.000168	CcSEcCtD
Cefpodoxime—Hyperhidrosis—Methotrexate—breast cancer	0.000167	0.000167	CcSEcCtD
Cefpodoxime—Discomfort—Epirubicin—breast cancer	0.000166	0.000166	CcSEcCtD
Cefpodoxime—Asthenia—Capecitabine—breast cancer	0.000166	0.000166	CcSEcCtD
Cefpodoxime—Malaise—Doxorubicin—breast cancer	0.000165	0.000165	CcSEcCtD
Cefpodoxime—Dry mouth—Epirubicin—breast cancer	0.000165	0.000165	CcSEcCtD
Cefpodoxime—Vertigo—Doxorubicin—breast cancer	0.000165	0.000165	CcSEcCtD
Cefpodoxime—Anorexia—Methotrexate—breast cancer	0.000164	0.000164	CcSEcCtD
Cefpodoxime—Syncope—Doxorubicin—breast cancer	0.000164	0.000164	CcSEcCtD
Cefpodoxime—Pruritus—Capecitabine—breast cancer	0.000164	0.000164	CcSEcCtD
Cefpodoxime—Leukopenia—Doxorubicin—breast cancer	0.000164	0.000164	CcSEcCtD
Cefpodoxime—Diarrhoea—Docetaxel—breast cancer	0.000164	0.000164	CcSEcCtD
Cefpodoxime—Confusional state—Epirubicin—breast cancer	0.000163	0.000163	CcSEcCtD
Cefpodoxime—Palpitations—Doxorubicin—breast cancer	0.000162	0.000162	CcSEcCtD
Cefpodoxime—Anaphylactic shock—Epirubicin—breast cancer	0.000161	0.000161	CcSEcCtD
Cefpodoxime—Hypotension—Methotrexate—breast cancer	0.000161	0.000161	CcSEcCtD
Cefpodoxime—Loss of consciousness—Doxorubicin—breast cancer	0.000161	0.000161	CcSEcCtD
Cefpodoxime—Cough—Doxorubicin—breast cancer	0.00016	0.00016	CcSEcCtD
Cefpodoxime—Shock—Epirubicin—breast cancer	0.000159	0.000159	CcSEcCtD
Cefpodoxime—Convulsion—Doxorubicin—breast cancer	0.000159	0.000159	CcSEcCtD
Cefpodoxime—Diarrhoea—Capecitabine—breast cancer	0.000159	0.000159	CcSEcCtD
Cefpodoxime—Dizziness—Docetaxel—breast cancer	0.000158	0.000158	CcSEcCtD
Cefpodoxime—Thrombocytopenia—Epirubicin—breast cancer	0.000158	0.000158	CcSEcCtD
Cefpodoxime—Hypertension—Doxorubicin—breast cancer	0.000158	0.000158	CcSEcCtD
Cefpodoxime—Musculoskeletal discomfort—Methotrexate—breast cancer	0.000157	0.000157	CcSEcCtD
Cefpodoxime—Hyperhidrosis—Epirubicin—breast cancer	0.000156	0.000156	CcSEcCtD
Cefpodoxime—Insomnia—Methotrexate—breast cancer	0.000156	0.000156	CcSEcCtD
Cefpodoxime—Myalgia—Doxorubicin—breast cancer	0.000156	0.000156	CcSEcCtD
Cefpodoxime—Chest pain—Doxorubicin—breast cancer	0.000156	0.000156	CcSEcCtD
Cefpodoxime—Anxiety—Doxorubicin—breast cancer	0.000155	0.000155	CcSEcCtD
Cefpodoxime—Paraesthesia—Methotrexate—breast cancer	0.000155	0.000155	CcSEcCtD
Cefpodoxime—Discomfort—Doxorubicin—breast cancer	0.000154	0.000154	CcSEcCtD
Cefpodoxime—Anorexia—Epirubicin—breast cancer	0.000154	0.000154	CcSEcCtD
Cefpodoxime—Dyspnoea—Methotrexate—breast cancer	0.000154	0.000154	CcSEcCtD
Cefpodoxime—Somnolence—Methotrexate—breast cancer	0.000153	0.000153	CcSEcCtD
Cefpodoxime—Dizziness—Capecitabine—breast cancer	0.000153	0.000153	CcSEcCtD
Cefpodoxime—Dry mouth—Doxorubicin—breast cancer	0.000152	0.000152	CcSEcCtD
Cefpodoxime—Vomiting—Docetaxel—breast cancer	0.000152	0.000152	CcSEcCtD
Cefpodoxime—Dyspepsia—Methotrexate—breast cancer	0.000152	0.000152	CcSEcCtD
Cefpodoxime—Rash—Docetaxel—breast cancer	0.000151	0.000151	CcSEcCtD
Cefpodoxime—Hypotension—Epirubicin—breast cancer	0.000151	0.000151	CcSEcCtD
Cefpodoxime—Dermatitis—Docetaxel—breast cancer	0.000151	0.000151	CcSEcCtD
Cefpodoxime—Confusional state—Doxorubicin—breast cancer	0.000151	0.000151	CcSEcCtD
Cefpodoxime—Decreased appetite—Methotrexate—breast cancer	0.00015	0.00015	CcSEcCtD
Cefpodoxime—Headache—Docetaxel—breast cancer	0.00015	0.00015	CcSEcCtD
Cefpodoxime—Anaphylactic shock—Doxorubicin—breast cancer	0.000149	0.000149	CcSEcCtD
Cefpodoxime—Gastrointestinal disorder—Methotrexate—breast cancer	0.000149	0.000149	CcSEcCtD
Cefpodoxime—Fatigue—Methotrexate—breast cancer	0.000149	0.000149	CcSEcCtD
Cefpodoxime—Pain—Methotrexate—breast cancer	0.000148	0.000148	CcSEcCtD
Cefpodoxime—Vomiting—Capecitabine—breast cancer	0.000147	0.000147	CcSEcCtD
Cefpodoxime—Musculoskeletal discomfort—Epirubicin—breast cancer	0.000147	0.000147	CcSEcCtD
Cefpodoxime—Shock—Doxorubicin—breast cancer	0.000147	0.000147	CcSEcCtD
Cefpodoxime—Thrombocytopenia—Doxorubicin—breast cancer	0.000146	0.000146	CcSEcCtD
Cefpodoxime—Rash—Capecitabine—breast cancer	0.000146	0.000146	CcSEcCtD
Cefpodoxime—Insomnia—Epirubicin—breast cancer	0.000146	0.000146	CcSEcCtD
Cefpodoxime—Dermatitis—Capecitabine—breast cancer	0.000146	0.000146	CcSEcCtD
Cefpodoxime—Headache—Capecitabine—breast cancer	0.000145	0.000145	CcSEcCtD
Cefpodoxime—Paraesthesia—Epirubicin—breast cancer	0.000145	0.000145	CcSEcCtD
Cefpodoxime—Hyperhidrosis—Doxorubicin—breast cancer	0.000144	0.000144	CcSEcCtD
Cefpodoxime—Dyspnoea—Epirubicin—breast cancer	0.000144	0.000144	CcSEcCtD
Cefpodoxime—Somnolence—Epirubicin—breast cancer	0.000144	0.000144	CcSEcCtD
Cefpodoxime—Anorexia—Doxorubicin—breast cancer	0.000142	0.000142	CcSEcCtD
Cefpodoxime—Nausea—Docetaxel—breast cancer	0.000142	0.000142	CcSEcCtD
Cefpodoxime—Feeling abnormal—Methotrexate—breast cancer	0.000142	0.000142	CcSEcCtD
Cefpodoxime—Dyspepsia—Epirubicin—breast cancer	0.000142	0.000142	CcSEcCtD
Cefpodoxime—Gastrointestinal pain—Methotrexate—breast cancer	0.000141	0.000141	CcSEcCtD
Cefpodoxime—Decreased appetite—Epirubicin—breast cancer	0.00014	0.00014	CcSEcCtD
Cefpodoxime—Hypotension—Doxorubicin—breast cancer	0.00014	0.00014	CcSEcCtD
Cefpodoxime—Gastrointestinal disorder—Epirubicin—breast cancer	0.000139	0.000139	CcSEcCtD
Cefpodoxime—Fatigue—Epirubicin—breast cancer	0.000139	0.000139	CcSEcCtD
Cefpodoxime—Pain—Epirubicin—breast cancer	0.000138	0.000138	CcSEcCtD
Cefpodoxime—Constipation—Epirubicin—breast cancer	0.000138	0.000138	CcSEcCtD
Cefpodoxime—Nausea—Capecitabine—breast cancer	0.000138	0.000138	CcSEcCtD
Cefpodoxime—Urticaria—Methotrexate—breast cancer	0.000137	0.000137	CcSEcCtD
Cefpodoxime—Abdominal pain—Methotrexate—breast cancer	0.000136	0.000136	CcSEcCtD
Cefpodoxime—Body temperature increased—Methotrexate—breast cancer	0.000136	0.000136	CcSEcCtD
Cefpodoxime—Musculoskeletal discomfort—Doxorubicin—breast cancer	0.000136	0.000136	CcSEcCtD
Cefpodoxime—Insomnia—Doxorubicin—breast cancer	0.000135	0.000135	CcSEcCtD
Cefpodoxime—Paraesthesia—Doxorubicin—breast cancer	0.000134	0.000134	CcSEcCtD
Cefpodoxime—Dyspnoea—Doxorubicin—breast cancer	0.000133	0.000133	CcSEcCtD
Cefpodoxime—Feeling abnormal—Epirubicin—breast cancer	0.000133	0.000133	CcSEcCtD
Cefpodoxime—Somnolence—Doxorubicin—breast cancer	0.000133	0.000133	CcSEcCtD
Cefpodoxime—Gastrointestinal pain—Epirubicin—breast cancer	0.000132	0.000132	CcSEcCtD
Cefpodoxime—Dyspepsia—Doxorubicin—breast cancer	0.000132	0.000132	CcSEcCtD
Cefpodoxime—Decreased appetite—Doxorubicin—breast cancer	0.00013	0.00013	CcSEcCtD
Cefpodoxime—Gastrointestinal disorder—Doxorubicin—breast cancer	0.000129	0.000129	CcSEcCtD
Cefpodoxime—Fatigue—Doxorubicin—breast cancer	0.000129	0.000129	CcSEcCtD
Cefpodoxime—Urticaria—Epirubicin—breast cancer	0.000128	0.000128	CcSEcCtD
Cefpodoxime—Constipation—Doxorubicin—breast cancer	0.000128	0.000128	CcSEcCtD
Cefpodoxime—Pain—Doxorubicin—breast cancer	0.000128	0.000128	CcSEcCtD
Cefpodoxime—Abdominal pain—Epirubicin—breast cancer	0.000128	0.000128	CcSEcCtD
Cefpodoxime—Body temperature increased—Epirubicin—breast cancer	0.000128	0.000128	CcSEcCtD
Cefpodoxime—Hypersensitivity—Methotrexate—breast cancer	0.000127	0.000127	CcSEcCtD
Cefpodoxime—Asthenia—Methotrexate—breast cancer	0.000124	0.000124	CcSEcCtD
Cefpodoxime—Feeling abnormal—Doxorubicin—breast cancer	0.000123	0.000123	CcSEcCtD
Cefpodoxime—Gastrointestinal pain—Doxorubicin—breast cancer	0.000122	0.000122	CcSEcCtD
Cefpodoxime—Pruritus—Methotrexate—breast cancer	0.000122	0.000122	CcSEcCtD
Cefpodoxime—Hypersensitivity—Epirubicin—breast cancer	0.000119	0.000119	CcSEcCtD
Cefpodoxime—Urticaria—Doxorubicin—breast cancer	0.000119	0.000119	CcSEcCtD
Cefpodoxime—Abdominal pain—Doxorubicin—breast cancer	0.000118	0.000118	CcSEcCtD
Cefpodoxime—Body temperature increased—Doxorubicin—breast cancer	0.000118	0.000118	CcSEcCtD
Cefpodoxime—Diarrhoea—Methotrexate—breast cancer	0.000118	0.000118	CcSEcCtD
Cefpodoxime—Asthenia—Epirubicin—breast cancer	0.000116	0.000116	CcSEcCtD
Cefpodoxime—Pruritus—Epirubicin—breast cancer	0.000114	0.000114	CcSEcCtD
Cefpodoxime—Dizziness—Methotrexate—breast cancer	0.000114	0.000114	CcSEcCtD
Cefpodoxime—Diarrhoea—Epirubicin—breast cancer	0.00011	0.00011	CcSEcCtD
Cefpodoxime—Hypersensitivity—Doxorubicin—breast cancer	0.00011	0.00011	CcSEcCtD
Cefpodoxime—Vomiting—Methotrexate—breast cancer	0.00011	0.00011	CcSEcCtD
Cefpodoxime—Rash—Methotrexate—breast cancer	0.000109	0.000109	CcSEcCtD
Cefpodoxime—Dermatitis—Methotrexate—breast cancer	0.000109	0.000109	CcSEcCtD
Cefpodoxime—Headache—Methotrexate—breast cancer	0.000108	0.000108	CcSEcCtD
Cefpodoxime—Asthenia—Doxorubicin—breast cancer	0.000107	0.000107	CcSEcCtD
Cefpodoxime—Dizziness—Epirubicin—breast cancer	0.000107	0.000107	CcSEcCtD
Cefpodoxime—Pruritus—Doxorubicin—breast cancer	0.000106	0.000106	CcSEcCtD
Cefpodoxime—Vomiting—Epirubicin—breast cancer	0.000103	0.000103	CcSEcCtD
Cefpodoxime—Nausea—Methotrexate—breast cancer	0.000103	0.000103	CcSEcCtD
Cefpodoxime—Diarrhoea—Doxorubicin—breast cancer	0.000102	0.000102	CcSEcCtD
Cefpodoxime—Rash—Epirubicin—breast cancer	0.000102	0.000102	CcSEcCtD
Cefpodoxime—Dermatitis—Epirubicin—breast cancer	0.000102	0.000102	CcSEcCtD
Cefpodoxime—Headache—Epirubicin—breast cancer	0.000101	0.000101	CcSEcCtD
Cefpodoxime—Dizziness—Doxorubicin—breast cancer	9.88e-05	9.88e-05	CcSEcCtD
Cefpodoxime—Nausea—Epirubicin—breast cancer	9.59e-05	9.59e-05	CcSEcCtD
Cefpodoxime—Vomiting—Doxorubicin—breast cancer	9.5e-05	9.5e-05	CcSEcCtD
Cefpodoxime—Rash—Doxorubicin—breast cancer	9.42e-05	9.42e-05	CcSEcCtD
Cefpodoxime—Dermatitis—Doxorubicin—breast cancer	9.41e-05	9.41e-05	CcSEcCtD
Cefpodoxime—Headache—Doxorubicin—breast cancer	9.36e-05	9.36e-05	CcSEcCtD
Cefpodoxime—Nausea—Doxorubicin—breast cancer	8.88e-05	8.88e-05	CcSEcCtD
